GRN and glioblastoma: Furthermore, a strong correlation between the degree of induction of the COSTAR signature and the ex vivo anti-glioblastoma efficacy across NADs provided circumstantial evidence for a causal role of this GRN (R = 0.72, P = 1.4 × 10−5; Extended Data Fig. 6g).